Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Comorbidity and other factors effecting smoking cessetion

Banu Salepci, Ali Fidan, Ferhan Karatas, Nesrin Kiral, Elif Torun Parmaksiz, Coskun Dogan, Gulsen Sarac
European Respiratory Journal 2014 44: P4159; DOI:
Banu Salepci
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Fidan
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferhan Karatas
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nesrin Kiral
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elif Torun Parmaksiz
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Coskun Dogan
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gulsen Sarac
1Department of Chest Diseases, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Objective: To determine the effect of comorbidity as well as other demographic, pulmonary function test and smoking- related parameters on smoking cessetion.

Methods: Between May-2013 – December-2013, smokers followed at least for one month were included. The demographic data, comorbid diseases, PFTs, smoking history and medication were recorded. The effect of comorbid disease as well as demographics, PFTs, smoking-related parameters on smoking cessetion were analyzed. Chi-square and Mann Whitney –U tests were used in statistical analysis.

Results: For 206 smokers, median follow up was 3 months and 121(58.7%) were male, 85(41.3%) were female. Mean age was 41.3±12.2 (16-79). Smoking history was 27.6 pack-years while mean Fagerstrom Dependence Score was 6.3. Comorbid disease was existing in 124(60.2%) cases. Physchiatric diseases 43(20.9%) were the leading comorbid disease followed by heart failure and hypertension (6.7% and 8.3% respectively). Of the cases, 74.8% has been discontinued even in the first month of follow-up and 1 month quitting rate (out of 206 patients) was 21.4% while it was 10.2% for 3 months (out of 128 patients). Comorbid diseases showed no statistically significant effect on quitting rates. Considering for 3-months-period, quitters were older (mean age:51.8 vs. 40.4; p=0.003), more heavy smokers ( 40.5 vs. 27.1 pack-years; p=0.006) and with lower FEV1/FVC ratio (71.9 vs. 77.9; p=0.049)

Conclusion: Many of the smokers who attempted to quit has failed in following smoking cessetion program. Comorbidity was not found to be effecting quitting rates. Older and more heavy smokers as well as smokers with relatively lower FEV1/FVC ratio were found to be more succesive in quitting smoking.

  • Smoking
  • Comorbidities
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comorbidity and other factors effecting smoking cessetion
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comorbidity and other factors effecting smoking cessetion
Banu Salepci, Ali Fidan, Ferhan Karatas, Nesrin Kiral, Elif Torun Parmaksiz, Coskun Dogan, Gulsen Sarac
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4159;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Comorbidity and other factors effecting smoking cessetion
Banu Salepci, Ali Fidan, Ferhan Karatas, Nesrin Kiral, Elif Torun Parmaksiz, Coskun Dogan, Gulsen Sarac
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4159;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Use of oral and nasal tobacco and asthma symptoms in a Nordic population
  • Waterpipe tobacco smoking may potentiate risk of fungal and bacterial infections
  • Chronic exposure to water-pipe smoke induces alveolar enlargement, DNA damage and impairment of lung function in mice
Show more 6.3 Tobacco, Smoking Control and Health Education

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society